Chemomab Therapeutics (CMMB) Operating Income (2011 - 2019)
Chemomab Therapeutics' Operating Income came in at $3.9 million for Q3 2019, up 55.6% from $2.51 million a year earlier but down 12.3% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Operating Income (2011 - 2019) Analysis & Trends
Over the trailing twelve months to Sep 30, 2019, Chemomab Therapeutics reported Operating Income of $16.75 million, up 40.2% year-over-year; for FY2018, it came in at -$13.04 million.
- Going back by year, Operating Income was -$9.39 million in FY2017 and -$4.64 million in FY2016.
- The five-year range for quarterly Operating Income is $1.88 million (Q4 2017) to $5.43 million (Q1 2019).
- Year-over-year, Operating Income has increased for four consecutive quarters, with growth averaging 45.1% over the last four quarters.
- Business Quant data shows CMMB's Operating Income at $4.44 million (Q2 2019), $5.43 million (Q1 2019) and $2.98 million (Q4 2018) in the three quarters before Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Chemomab Therapeutics | 6.82 Mn | -28.33 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 3.90 Mn |
| Jun 30, 2019 | 4.44 Mn |
| Mar 31, 2019 | 5.43 Mn |
| Dec 31, 2018 | 2.98 Mn |
| Sep 30, 2018 | 2.51 Mn |
| Jun 30, 2018 | 4.16 Mn |
| Mar 31, 2018 | 3.40 Mn |
| Dec 31, 2017 | 1.88 Mn |
| Dec 31, 2012 | 1.40 Mn |
| Sep 30, 2012 | 588,086.38 |
| Jun 30, 2012 | 1.89 Mn |
| Dec 31, 2011 | 1.77 Mn |
| Sep 30, 2011 | 1.36 Mn |
| Jun 30, 2011 | 1.36 Mn |
API Access
Chemomab Therapeutics Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();